Back

Post-infarct VT substrate ablation based on evoked delayed potential elimination as well-defined target: results from a prospective multicenter study.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome? Ablation of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Marta De Riva Silva

Leiden University Medical Center, Leiden (Netherlands (The))

3 More presentations in this session

Presentation thumbnail
Anatomical-based percutaneous left stellate ganglion block in patients with refractory electrical storm: efficacy and safety.
Doctor S. Compagnoni (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Stellate ganglion blockade for treatment of ventricular arrhythmia storm: A meta-analysis
Doctor S. Zafeiropoulos (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Long-term toxicity of radiosurgery for ablation of ventricular tachycardia
Mr J. Cvek (Ostrava, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Interventional treatment for ventricular tachycardia in structural heart disease: new approaches for better outcome?

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of ventricular tachycardia ablation in patients presenting with electrical storm
thumbnail
Congress Presentation
Efficacy and safety of catheter ablation versus antiarrhythmic drug therapy in ventricular tachycardia management: a systematic review and meta-analysis
thumbnail
Congress Presentation
ECG vs ECGi to predict the area of interest in VT ablation in structural heart disease patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources